BSBMTCT Guidelines Sub-Committee

Chair:

Dr Andrew Clark

Members:

Emma Nicholson (Vice Chair),Erin Hurst, Victoria Potter, Muhammad Saif, Eleni Tholouli, Victoria Campbell, Anjum Khan, Sara Lorenzo Cerrado

Terms of Reference:

Guidelines Sub-Committee Terms of Reference_Feb_2023

Guidelines:

  1. UK Clinical Community Consensus on the Emerging use of PTCy 2025
  2. UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation(HSCT): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies (BSBMTCT), NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group, UK Cancer Genetics Group (UKCGG) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping(UK NEQAS LI) 2025
  3. UK consensus statement on the use of plerixafor in healthy stem cell donors 2025
  4. Practice guideline: Preparation for CAR T-cell therapy in children and young adults with B-acute lymphoblastic leukaemia 2024
  5. Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children’s cancer and Leukaemia Group (CCLG), and British Infection Association (BIA) Vaccination consensus statement 2023
  6. Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Clinical Genetics Group (UKCGG), CanGene-CanVar,NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT) 2023

 

Top